Pathophysiology of Headache—Past and Present
Michael A. Moskowitz MD, M.Sc. (Hon),
Michael A. Moskowitz MD, M.Sc. (Hon)
Search for more papers by this authorMichael A. Moskowitz MD, M.Sc. (Hon),
Michael A. Moskowitz MD, M.Sc. (Hon)
Search for more papers by this authorAddress all correspondence to Dr. Michael A. Moskowitz, Massachusetts General Hospital, 149 13th Street, Room 6403, Stroke and Neurovascular Regulation Laboratory, Charlestown, MA 02129-2020, USA.
From the Harvard-MIT Division of Health Science and Technology, Cambridge, MA, USA; and Stroke and Neurovascular Regulation Laboratory, Massachusetts General Hospital, Charlestown, MA, USA.
REFERENCES
- 1 Moskowitz MA, Reinhard JF Jr, Romero J, Melamed E, Pettibone DJ. Neurotransmitters and the fifth cranial nerve: Is there a relation to the headache phase of migraine? The Lancet. 1979; 2: 883-885.
- 2 Liu-Chen LY, Mayberg MR, Moskowitz MA. Immunohistochemical evidence for a substance P-containing trigeminovascular pathway to pial arteries in cats. Brain Res. 1983; 268: 162-166.
- 3 Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol. 1984; 16: 157-168.
- 4 Edvinsson L. Sensory nerves in man and their role in primary headaches. Cephalalgia. 2001 Sep; 21(7): 761-4.
- 5 Jansen I, Uddman R, Ekman R, Olesen J, Ottosson A, Edvinsson L. Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides. 1992 May-Jun; 13(3): 527-36.
- 6 Levy D, Burstein R, Strassman AM. Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann Neurol. 2005 Nov; 58(5): 698-705.
- 7 Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J. CGRP may play a causative role in migraine. Cephalalgia. 2002 Feb; 22(1): 54-61.
- 8 Strassman AM, Levy D. Response properties of dural nociceptors in relation to headache. J Neurophysiol. 2006 Mar; 95(3): 1298-306.
- 9 Olesen J, Diener HC, Husstedt IW, et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004; 350: 1104-1110.
- 10 Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981; 9: 344-352.
- 11 Cao Y, Welch KMA, Aurora S, et al. Functional MRI-BOLD of visually triggered headache in patients with migraine. Arch Neurol. 1999; 56: 548-554.
- 12 Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA. 2001; 98: 4687-4692.
- 13 Chen G, Dunbar RL, Gao W, Ebner TJ. Role of calcium, glutamate neurotransmission, and nitric oxide in spreading acidification and depression in the cerebellar cortex. J Neurosci. 2001; 21: 9877-9887.
- 14 Van Harreveld A, Fifkova E. Glutamate release from the retina during spreading depression. J Neurobiol. 1970; 2: 13-29.
- 15 Marrannes R, Willems R, De Prins E, Wauquier A. Evidence for a role of the N-methyl-D-aspartate (NMDA) receptor in cortical spreading depression in the rat. Brain Res. 1988 Aug 9; 457(2): 226-40.
- 16 Lauritzen M, Hansen AJ. The effect of glutamate receptor blockade on anoxic depolarization and cortical spreading depression. J Cereb Blood Flow Metab. 1992 Mar; 12(2): 223-9.
- 17 Anderson TR, Andrew RD. Spreading depression: imaging and blockade in the rat neocortical brain slice. J Neurophysiol. 2002 Nov; 88(5): 2713-25.
- 18 Moskowitz MA, Bolay H, Dalkara T. Deciphering migraine mechanisms: Clues from familial hemiplegic migraine genotypes. Ann Neurol. 2004; 55: 276-280.
- 19 Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type 2 are caused by mutations in the calcium channel gene CACNLIA4. Cell. 1996; 87: 543-552.
- 20 De Fusco M, Marconi R, Silvestri L, et al Haplioinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit gene is responsible for familial hemiplegic migraine type 2. Nat Genet. 2003; 33: 192-196.
- 21 Iadecola C. From CSD to headache: A long and winding road. Nat Med. 2002; 8: 110-112.
- 22 Van Den Maagdenbeurg AM, Pietrobon D, Pizzorusso T, et al. A Cacna1a knockin migrainene mouse model with increased susceptibility to cortical spreading depression. Neuron. 2004; 41: 701-710.
- 23 Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol. 2006 Apr; 59(4): 652-61.
- 24 Moskowitz MA, Nozaki K, Kraig RP. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci. 1993; 13: 1167-1177.
- 25 Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002; 8: 136-142.
- 26 Moskowitz MA. Cluster headache: Evidence for a pathophysiologic focus in the superior pericarotid cavernous sinus plexus. Headache. 1988; 28: 584-586.
- 27 Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest. 2004; 113: 1447-1455.
- 28 Woods RP, Iacoboni M, Mazziotta JC. Brief report: Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med. 1994; 331: 1689-1692.
